Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-FR Version v5-EN
Language French English
Date Updated 2024-08-01 2024-04-02
Drug Identification Number 02517132 02517132
Brand name DEXTROSE INJECTION DEXTROSE INJECTION
Common or Proper name DEXTROSE INJECTION DEXTROSE INJECTION
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients DEXTROSE DEXTROSE
Strength(s) 50% 50%
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 x 50mL vial / fiole 10 x 50mL vial / fiole
ATC code B05BA B05BA
ATC description I.V. SOLUTIONS I.V. SOLUTIONS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2024-04-01 2024-04-01
Actual start date 2024-04-01 2024-04-01
Estimated end date 2024-08-31 2024-05-31
Actual end date 2024-07-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Omega has made the decision to re-instate an allocation for Omega Dextrose to prevent overstocking of the Canadian labeled product. Omega has made the decision to re-instate an allocation for Omega Dextrose to prevent overstocking of the Canadian labeled product.
Health Canada comments